5 ms·
I think in years to come, the story of the AstraZeneca vaccine is going to make for some fascinating documentaries. The whole thing has been a series of weird p
by rsynnott 6y ago
I think in years to come, the story of the AstraZeneca vaccine is going to make for some fascinating documentaries. The whole thing has been a series of weird problems from start to finish (starting with AZ being chosen as the partner in the first place, arguably).
- zpeti 6y agoSeems to be working just fine in the UK, US, India, Hungary, so I don't think any of the issues are to do with Astrazeneca. But the politics of it, absolutely.
- te_chris 6y agoIt’s not authorised in the US and the federal regulators keep raising their eyebrows at the data.
- kmlx 6y agothis is something i don’t get: if it works all around the world why aren’t the federal regulators simply fast tracking its approval? are they not allowed to do that?
- dtf 6y agoObservational studies are a lower standard of evidence than randomised controlled trials. Countries with higher levels of vaccine skepticism (eg the US) seem to be erring on the side of doing things by the book. The UK, by comparison, enjoys a high degree of trust in its healthcare system and can afford to be a little more gung-ho.
- kmlx 6y agointeresting thanks. how long would a randomised controlled trial take?
- dtf 6y agoThe AstraZeneca US phase 3 trial took about 7 months. https://clinicaltrials.gov/ct2/show/NCT04516746 https://clinicaltrials.gov/ct2/show/NCT04516746 In this case, US regulators took issue with the company's press release, rather than the results of the trial itself.
- levosmetalo 6y agoWho says AZ works around the world? It's the vaccine of the last resort, people will get it only if they can't get anything else because it's still better than nothing, at least for now. And "better than nothing" is just temporary because AZ is very to completely ineffective against all virus mutations that are currently spreading. If Russian and Chinese Sputnik and Sinovac vaccines were approved in the EU, we could save so many lives, but politics will rather try to force AZ than accept that they failed.
- kmlx 6y ago> Who says AZ works around the world? all the authorities that have approved it? all the people that got it? we're talking tens of millions of people and authorities across the planet.
- levosmetalo 6y agoand those authorities approved it because it's good and effective, or because it's the only one available on the market?
- tinus_hn 6y agoBecause normally they can get away with a drawn out process that takes years, and if in one country some medication is curing cancer and in another country is not approved, nobody bats an eyelid. It’s a big bunch of fiefdoms that all want to do their own checks and it is a political minefield. Witness the ridiculous situation with the vaccination shutdown last week. Has nothing to do with science, everything with public image and politics. And it’s setting themselves up to fail as well because in this situation if a manufacturer has contracts with countries A and B and A pays more, they’ll just focus on approval for country A and delay approval for country B, so it’s perfectly defensible to only deliver to country A and not the country who isn’t going to use it anyway. Unfortunately this is all smoke and mirrors that goes way over the head of the general public so there’s no backlash for failing.
- rsynnott 6y agoAZ has had severe production issues. AZ's working in the UK because they're getting most of the production, but they've delivered only a small fraction of what they said they would in the EU. They've also had _two_ botched trials now, leading to delays in approval (a couple of months for the EU, nearly six months for the US). And now this.
- varispeed 6y agoAren't the issues created by over-regulation and bureaucrats throwing their spanners everywhere to cover their own incompetence?
- Denvercoder9 6y agoThere's no evidence supporting that claim, and there have been no such problems with the Pfizer, Moderna and Johnson vaccins which had to comply with the same regulations.
- varispeed 6y agoThese other vaccines are produced for profit so there is money to be made under the table for bureaucrats, whereas AZ does not have this potential. If bureaucrats can stamp out this vaccine they can make more money pushing the others. Have you not seen the fake news about blood clots and other scare mongering to make people want to use other vaccines?
- Denvercoder9 6y agoHanlon's razor. Never attribute to malice what can be explained by incompetence. There's absolutely no evidence at all supporting your allegations.
- varispeed 6y agoWould that be a coincidence then that only vaccine made not for profit has such problems? Strange news coming? Allegations? I think this may be both incompetence and corruption. We'll see - I hope this will be properly investigated including the bureaucrats involved in the decisions and their financial affairs.
- micdr0p 6y agoThe AZ shot hasn't been approved in the US yet. They also released a study there where they're suspected of cherry-picking data to make it look good https://www.niaid.nih.gov/news-events/niaid-statement-astrazeneca-vaccine https://www.niaid.nih.gov/news-events/niaid-statement-astraz...
- kmlx 6y agojust last week AZN told the UK gov to not expect large quantities due to manufacturing issues in their UK plants.
- brnt 6y agoI've not been following AZ more closely than knowing why vaccinations in my country are delayed. What are the weird problems and events you speak of?
- markus92 6y agoOverselling their production capacity by a lot, for one. The major protocol violations in their trials and the weird way they are handling it, are another.
- krona 6y agoThere was no production capacity 12 months ago. EU suppliers failed to upgrade and improve yields sufficiently in time. The UK/US started expanding right at the start of the pandemic, so effectively had a 6-8 month head start.
- markus92 6y agoEasy to say but not necessarily true. Let's look at the Halix factory, which is the main point of contention in the EU/UK dispute. The Dutch government (thus, EU) already offered them a major contract in March/April '20, for precisely this purpose. They already had started expanding in Feb '20 as part of their production for the AZ trial, so they declined.
- sampo 6y ago> Overselling their production capacity by a lot, for one. They grow live virus in live cell cultures. Scaling bioreactors from 50 liter test reactors to 1000 or 2000 liter production size reactors can be tricky. Even when everything goes well, bioreactors can have 3-fold differences in yield. I would assume either AZ quoted the ideal production capacity. Or maybe AZ quoted a range, and EU politicians took the maximum of the range and believed that would be achievable.
- yread 6y ago> Scaling bioreactors from 50 liter test reactors to 1000 or 2000 liter production size reactors can be tricky Yes, especially if you've never done vaccine production before!
- kmlx 6y agoi think it’s due to the fact AZN isn’t a traditional vaccine producer. what’s most striking to me is the complete silence (till recently) of the big 3 vaccine manufacturers: gsk, merck and sanofi. no vaccines from the biggest producers? an interesting article that i found about this strange situation: https://www.google.co.uk/amp/s/amp.ft.com/content/657b123a-78ba-4fba-b18e-23c07e313331 https://www.google.co.uk/amp/s/amp.ft.com/content/657b123a-7...
- ImprovedSilence 6y agoI heard merck is partnered with J&J to help make their vaccine.
- kmlx 6y agoyes, after the Biden admin made a push. otherwise i don't think they would have gotten involved imo.
- dtf 6y agoMerck was the Oxford team's first choice of manufacturer. But the UK health minister overruled and told them they needed to use a British manufacturer. [1] "[T]he Oxford-AstraZeneca vaccine was very nearly the Oxford-Merck vaccine - and under the terms of the agreement with the American pharmaceutical giant, there were no guarantees of supply. The episode played out against the backdrop of the first phase of the pandemic. During March and April 2020, the University of Oxford negotiated a deal which would allow Merck to manufacture and distribute the vaccine it was in the process of developing. The arrangement made sense. Unlike British-Swedish AstraZeneca, Merck had experience in making vaccines. Its senior executives had links to Oxford scientist and government adviser Sir John Bell. Yet when the contract reached Matt Hancock's desk, the former adviser said, the health secretary refused to approve it, because it didn't include provisions specifically committing to supply the UK first." [1] https://news.sky.com/story/covid-19-rejected-contracts-and-a-hollywood-movie-how-uk-struck-deal-to-guarantee-vaccine-supply-12204044 https://news.sky.com/story/covid-19-rejected-contracts-and-a...
- 6y ago
- byroot 6y agoAccording to "Le Canard Enchainé" [0] this is because: - They agreed not to make profits on the vaccines for the first year or so (that was imposed by Oxford)[1] - There's no penalty for not reaching the delivery targets in their contract with the EU. So since they have no financial incentives in delivering more, they simply subcontracted the production, and are not making much effort in solving the various production issues. [0] A famous, print only, French political news-paper, which is generally considered quite reliable. [1] https://www.ft.com/content/c474f9e1-8807-4e57-9c79-6f4af145b686 https://www.ft.com/content/c474f9e1-8807-4e57-9c79-6f4af145b...
- snowwolf 6y agoA lot of their problems seem to come down to the fact that they aren't experienced in vaccines so have made multiple missteps along the way because of that on the procedural side of things. Their choice as partner for the Oxford vaccine was purely political. Merck were originally the preferred choice (and they have a lot of vaccine experience) and a deal was almost done, but the UK vetoed it because all production would be in the US and they wouldn't offer the guarantees the UK had gotten from Oxford as part of their funding of the Vaccine development. https://www.theguardian.com/society/2021/jan/29/we-had-to-go-it-alone-how-the-uk-got-ahead-in-the-covid-vaccine-race https://www.theguardian.com/society/2021/jan/29/we-had-to-go...
- klelatti 6y agoIf it was all in the US then none would have been exported to either UK or EU? Seems like a good call.
- snowwolf 6y agoDefinitely. The EU had the same opportunity with BioNTech which was funded by Germany. But they allowed a partnership with Pfizer and now the US gets most of that production.